Monte Rosa Therapeutics Inc (GLUE)
8.48
-0.15
(-1.74%)
USD |
NASDAQ |
Nov 14, 16:00
8.48
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics PE Ratio
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| November 14, 2024 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio Benchmarks
| Novartis AG | 12.12 |
| MEI Pharma Inc | 1.127 |
| Evoke Pharma Inc | -- |
| Revance Therapeutics Inc | -- |
| Vera Therapeutics Inc | -- |
PE Ratio Related Metrics
| Price to Book Value | 2.316 |
| Price | 8.48 |
| Earnings Yield | -26.42% |
| Market Cap | 520.44M |